Capula Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Buy
27,200
+100
+0.4% +$2.66K 0.01% 415
2025
Q4
$675K Sell
27,100
-14,800
-35% -$373K ﹤0.01% 350
2025
Q3
$1.07M Sell
41,900
-124,600
-75% -$3.08M 0.01% 352
2025
Q2
$4.04M Sell
166,500
-9,600
-5% -$224K 0.04% 84
2025
Q1
$4.46M Buy
176,100
+169,200
+2,452% +$4.43M 0.02% 148
2024
Q4
$183K Buy
+6,900
New +$187K ﹤0.01% 309
2024
Q3
Sell
-11,600
Closed -$325K 606
2024
Q2
$325K Buy
+11,600
New +$319K ﹤0.01% 361
2023
Q4
Sell
-22,100
Closed -$733K 520
2023
Q3
$733K Buy
+22,100
New +$782K 0.02% 278
2023
Q2
Sell
-244,800
Closed -$9.99M 704
2023
Q1
$9.99M Sell
244,800
-528,000
-68% -$22.8M 0.12% 149
2022
Q4
$39.6M Buy
772,800
+541,600
+234% +$26M 0.53% 45
2022
Q3
$10.1M Sell
231,200
-257,600
-53% -$12.5M 0.14% 176
2022
Q2
$25.6M Buy
488,800
+232,400
+91% +$11.8M 0.44% 65
2022
Q1
$13.3M Buy
+256,400
New +$13.3M 0.19% 109
2021
Q4
Sell
-93,400
Closed -$4.02M 631
2021
Q3
$4.02M Sell
93,400
-49,800
-35% -$2.21M 0.05% 268
2021
Q2
$5.56M Buy
143,200
+111,200
+348% +$4.32M 0.09% 177
2021
Q1
$1.16M Buy
+32,000
New +$1.14M 0.02% 338
2020
Q3
Sell
-649,475
Closed -$20.1M 282
2020
Q2
$20.1M Buy
649,475
+190,985
+42% +$6.49M 0.72% 27
2020
Q1
$14.2M Buy
458,490
+233,566
+104% +$7.96M 0.51% 52
2019
Q4
$8.36M Buy
+224,924
New +$8.01M 0.18% 127

Other funds holding PFE

Capula Management's PFE Position: Q1 2026 in Review

Capula Management reduced its Pfizer (PFE) stake by 86% in Q1 2026, selling an estimated $148K and leaving 929 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Capula Management first reported a position in PFE in Q1 2020 and has held it in 17 quarters since. The position peaked at $9.97M in Q2 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Capula Management held 929 shares of Pfizer worth $26.1K as of Q1 2026.
  • Capula Management sold 5,543 Pfizer shares in Q1 2026, an estimated $148K.
  • Pfizer made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1030 holding.
  • Capula Management first reported a position in Pfizer in Q1 2020 and has held it in 17 quarters since.
  • Capula Management's Pfizer position peaked at $9.97M in Q2 2020.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.